NPCE vs LUNG
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 14, 2026
NPCE
LUNG
Investment Advisor Scores
LUNG
AI Analyst Insights
Detailed Metrics Comparison
| Metric | NPCE | LUNG | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 28.3286 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -2.0% | -4.6% | NPCE |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 51.6/100 | 29.3/100 | NPCE |
| Profit Margin | -21.7% | -55.0% | NPCE |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | SELL | NPCE |
Relative Price Performance (Last 90 Days)
Current Technical Phase
NPCE
MarkdownPrice below a falling SMA50 (slope -4.7%), weak momentum, RSI 43
LUNG
MarkupPrice above SMA50, rising 50-day trend (14.1% over 20 days), RSI 64
Fundamentals Snapshot
| Metric | NPCE | LUNG |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -63.1 | -2.4 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.0% |
| Gross Margin | 0.8% | 0.8% |
| Operating Margin | -0.2% | -0.4% |
| EPS | -0.45 | -1.15 |
| Dividend Yield | — | — |